Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
Clinical trial NCT00078637 · COMPLETED
Trial details
- NCT number
- NCT00078637
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.